Your browser doesn't support javascript.
loading
Bispecific antibody targeting both B7-H3 and PD-L1 exhibits superior antitumor activities.
Li, Hua-Ying; Chen, Yi-Li; Deng, Xiang-Nan; Li, Huan-Huan; Tan, Jie; Liu, Guo-Jian; Zheng, Yu-Juan; Pei, Min; Peng, Kai-Ting; Yue, Li-Li; Chen, Xiao-Jia; Liu, Yu; Zhao, Yong-Shan; Wang, Chun-He.
Afiliação
  • Li HY; Shanghai Mabstone Biotechnologies, Ltd., Shanghai, 201203, China.
  • Chen YL; School of Life Science and Bio-Pharmaceutics, Shenyang Pharmaceutical University, Shenyang, 110016, China.
  • Deng XN; Biotherapeutics Discovery Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Li HH; Shanghai Mabstone Biotechnologies, Ltd., Shanghai, 201203, China. cheny@dartsbio.com.
  • Tan J; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Liu GJ; Shanghai Mabstone Biotechnologies, Ltd., Shanghai, 201203, China.
  • Zheng YJ; Shanghai Mabstone Biotechnologies, Ltd., Shanghai, 201203, China.
  • Pei M; Dartsbio Pharmaceuticals, Ltd., Zhongshan, 528400, China.
  • Peng KT; Biotherapeutics Discovery Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Yue LL; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Chen XJ; Shanghai Mabstone Biotechnologies, Ltd., Shanghai, 201203, China.
  • Liu Y; Institute of Biomedicine & Department of Cell Biology, Jinan University, National Engineering Research Center of Genetic Medicine, Guangzhou, 510632, China.
  • Zhao YS; Biotherapeutics Discovery Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Wang CH; University of Chinese Academy of Sciences, Beijing, 100049, China.
Acta Pharmacol Sin ; 44(11): 2322-2330, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37328649
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Antígeno B7-H1 / Receptor de Morte Celular Programada 1 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Acta Pharmacol Sin Assunto da revista: FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Antígeno B7-H1 / Receptor de Morte Celular Programada 1 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Acta Pharmacol Sin Assunto da revista: FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China